MIAN, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.627
EU - Europa 1.697
AS - Asia 1.340
SA - Sud America 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 12.689
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.608
CN - Cina 763
IT - Italia 703
SG - Singapore 421
SE - Svezia 237
DE - Germania 183
FI - Finlandia 175
GB - Regno Unito 126
FR - Francia 117
VN - Vietnam 110
UA - Ucraina 52
IE - Irlanda 29
CA - Canada 19
NL - Olanda 18
GR - Grecia 14
HK - Hong Kong 14
IN - India 14
TR - Turchia 11
RU - Federazione Russa 10
BG - Bulgaria 9
AR - Argentina 6
BE - Belgio 5
CZ - Repubblica Ceca 5
BR - Brasile 4
EU - Europa 4
AU - Australia 3
PE - Perù 3
PL - Polonia 3
SI - Slovenia 3
AL - Albania 2
JP - Giappone 2
ME - Montenegro 2
NZ - Nuova Zelanda 2
RO - Romania 2
TZ - Tanzania 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
IQ - Iraq 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
Totale 12.689
Salva come PNG Salva come JPEG
Città #
Fairfield 1.733
Woodbridge 939
Ashburn 762
Chandler 733
Houston 697
Cambridge 615
Seattle 611
Ann Arbor 595
Wilmington 562
Singapore 350
Boardman 243
Beijing 200
Jacksonville 200
Princeton 182
Padova 171
San Diego 160
Santa Clara 159
Medford 113
Des Moines 112
Dong Ket 109
Helsinki 84
Nanjing 77
Roxbury 64
Milan 45
Guangzhou 42
Columbus 38
London 34
Jinan 32
Dublin 29
Shenyang 29
Falls Church 27
Nanchang 26
New York 26
Ogden 24
Changsha 23
Hebei 21
Norwalk 20
Tianjin 19
Jiaxing 18
Redwood City 17
Kunming 16
Los Angeles 16
Rome 16
Washington 16
Dallas 14
Hong Kong 14
Munich 14
Hefei 12
Kharkiv 12
Kilburn 12
Zhengzhou 10
Bari 9
Borås 9
Fuzhou 8
Naples 8
North York 8
Phoenix 8
Sofia 8
Taizhou 8
Trieste 8
Dearborn 7
Florence 7
Mestre 7
Taiyuan 7
Tappahannock 7
Bologna 6
Buenos Aires 6
Chiswick 6
Haikou 6
Hounslow 6
Paris 6
Turin 6
Venice 6
Vigonza 6
Aprilia 5
Frankfurt am Main 5
Genoa 5
Ningbo 5
Prescot 5
Rockville 5
Shanghai 5
Cagliari 4
Hangzhou 4
Lappeenranta 4
Livorno 4
Rende 4
Acton 3
Amsterdam 3
Berlin 3
Brno 3
Carrù 3
Castelbellino 3
Catania 3
Cesiomaggiore 3
Chengdu 3
Detroit 3
Eskişehir 3
Formia 3
Groningen 3
Indiana 3
Totale 10.353
Salva come PNG Salva come JPEG
Nome #
L’elastosonografia come sostituto dell’esame citologico nei nodi soffici 325
0C22 men2A da mutazione di ret C6009S. descrizione di una grande famiglia 285
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 238
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 204
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 195
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 163
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 152
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 149
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 144
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 139
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 138
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 138
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 137
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 125
Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience 121
Calcitonin measurement and immunoassay interference: A case report and literature review 119
MEN2A/FMTC AND THE V804M RET MUTATION 118
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 117
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption. 117
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 115
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 114
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 114
Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves’ orbitopathy: a small prospective pilot study 114
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 113
Iodine status from childhood to adulthood in females living in North-East Italy: Iodine deficiency is still an issue. 112
Association of primary aldosteronism with chronic thyroiditis 110
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ) 110
Sodium/iodide symporter in thyroid cancer 109
Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening 109
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. 108
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 107
Normal values for thyroid ultrasonography, goiter prevalence and urinary iodine concentration in schoolchildren of the Veneto Region, Italy 106
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 104
BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer 104
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 102
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 102
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 101
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 101
INFLUENCE OF PHYSIOLOGICAL DIETARY SELENIUM SUPPLEMENTATION ON THE NATURAL COURSEOF AUTOIMMUNE THYROIDITIS 100
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series 100
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 100
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 98
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 98
The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer 98
Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines 98
Milk represents an important source of iodine in schoolchildren of the Veneto region, Italy 97
Restricted intraindividual urinary iodine concentration variability in nonfasting subjects 96
Familial nonsyndromic pheochromocytoma. 95
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 95
Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas 94
A Multiomodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients 94
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 94
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study 94
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. 93
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 93
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 93
Deregulated expression of aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients. 92
Sodium iodide symporter and pendrin expression in human thyroid tissues 92
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 92
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. 91
Follicular Thyroid Carcinoma with Metastases to the Pituitary Causing Pituitary Insufficiency. 89
Deregulated expression of VHL mRNA variants in papillary thyroid cancer 89
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 89
HEX, PAX-8 and TTF-1 gene expression in human thyroid tissues: a comparative analysis with other genes involved in iodide metabolism 85
The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways. 85
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 85
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 83
Expression of pendrin and the Pendred Syndrome (PDS) gene in human thyroid tissues 83
The antiproliferative effects of ouabain and everolimus on adrenocortical tumor cells. 82
Galectin-3 cytotest in thyroid follicular neoplasia: a prospective,monoinstitutional study 81
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 81
PDCD4 expression in thyroid neoplasia 80
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 80
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 80
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation 79
High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma. 79
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 79
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 79
Frequent TSH Receptor Genetic Alterations with Variable Signaling Impairment in a Large Series of Children with Nonautoimmune Isolated Hyperthyrotropinemia. 78
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 78
Medullary thyroid carcinoma: Clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986 77
Insulin autoimmune syndrome: from diagnosis to clinical management 77
Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer 76
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations 76
Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation. 75
Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. 74
Evidence of a low prevalence of a ras mutations in a large medullary thyroid cancer series. 74
Comparison of Calcium and Pentagastrin Tests for the Diagnosis and Follow-Up of Medullary Thyroid Cancer 73
The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma. 73
Na+/I- symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues 73
In papillary thyroid carcinoma BRAF(V600E) is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval. 73
Real-world performance of ATA risk estimates in predicting 1-year DTC outcomes: A prospective multicenter study of 2000 patients (ITCO Study #3) 73
Galectin-3 expression in thyroid fine needle cytology (t-FNAC) uncertain cases: Validation of molecular markers and technology innovation 72
Thyroid node assessment: how can we avoid unnecessary surgical procedures? 72
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study 71
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 71
The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations 70
CTLA-4 and PD-1 ligand gene expression in epithelial thyroid cancers 70
Dose giornaliera ottimale di Levotiroxina nel trattamento dell'ipotiroidismo primario 69
RET codon 609 mutations: a contribution for better clinical managing 68
Totale 10.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.701
article - articoli 48.307
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 414
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.033 0 0 0 0 263 188 295 298 386 302 161 140
2020/20212.125 103 190 130 166 58 147 81 178 257 336 207 272
2021/20222.095 66 223 211 167 166 129 138 218 144 56 172 405
2022/20231.546 314 200 14 204 216 216 17 85 168 23 69 20
2023/20241.106 41 106 158 91 101 106 121 63 61 56 106 96
2024/20251.161 35 242 247 200 437 0 0 0 0 0 0 0
Totale 12.856